Company · CIK 0001009356 · SIC 2834 — Pharmaceutical Preparations
SALIX PHARMACEUTICALS LTD · SLXP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2015 DUForm 4 → | Apr 3, 11:58 am EDT | Rick D ScruggsExecutive Vice President | 74,962 | $173.00 | $12,968,426 | 0 | — | plan? |
| Apr 1, 2015 DForm 4 → | Apr 3, 11:53 am EDT | William P ForbesPresident, Medical, R&D & CDO | 51,714 | $173.00 | $8,946,522 | 0 | — | plan? |
| Apr 1, 2015 DUForm 4 → | Apr 3, 11:45 am EDT | Alonzo Thomas DActing President and CEO, Director | 113,877 | $173.00 | $19,700,721 | 0 | — | plan? |
| Apr 1, 2015 DUForm 4 → | Apr 3, 11:43 am EDT | Timothy J CreechSee Remarks | 25,437 | $173.00 | $4,400,601 | 0 | — | plan? |
| Apr 1, 2015 DUForm 4 → | Apr 3, 11:40 am EDT | William P KeaneDirector | 39,160 | $173.00 | $6,774,680 | 0 | — | plan? |
| Apr 1, 2015 DUForm 4 → | Apr 3, 11:36 am EDT | William C Bertrand Jr.See Remarks | 31,258 | $173.00 | $5,407,634 | 0 | — | plan? |
| Apr 1, 2015 DForm 4 → | Apr 3, 11:32 am EDT | John F ChappellDirector | 322,764 | $173.00 | $55,838,172 | 0 | — | plan? |
| Apr 1, 2015 DUForm 4 → | Apr 3, 11:29 am EDT | Mark A SirgoDirector | 37,427 | $173.00 | $6,474,871 | 0 | — | plan? |
| Mar 9, 2015 GForm 4 → | Mar 13, 4:28 pm EDT | William P KeaneDirector | 600 | — | — | 39,160 | — | plan? late |
| Mar 9, 2015 SForm 4 → | Mar 11, 4:41 pm EDT | William P ForbesPresident, Medical R&D and CDO | 42,880 | $157.84 | $6,768,179 | 51,714 | −45.3% | plan? |
| Mar 6, 2015 SForm 4 → | Mar 9, 5:01 pm EDT | Rick D ScruggsExecutive Vice President | 4,000 | $157.55 | $630,200 | 74,962 | −5.07% | plan? |
| Mar 6, 2015 SForm 4 → | Mar 9, 4:56 pm EDT | William P ForbesEVP Research&Devel & CDO | 20,000 | $157.96 | $3,159,200 | 94,594 | −17.5% | plan? |
| Mar 6, 2015 SForm 4 → | Mar 9, 1:40 pm EDT | Timothy J CreechSee Remarks | 4,600 | $157.67 | $725,269 | 25,437 | −15.3% | plan? |
| Mar 6, 2015 GForm 4 → | Mar 9, 1:40 pm EDT | Timothy J CreechSee Remarks | 500 | — | — | 30,037 | — | plan? |
| Feb 2, 2015 AForm 4 → | Feb 4, 5:06 pm EST | Alonzo Thomas DActing Chief Executive Officer, Director | 14,662 | — | — | 95,587 | — | plan? |
| Jan 31, 2015 AForm 4 → | Feb 3, 4:15 pm EST | William C Bertrand Jr.See Remarks | 2,851 | — | — | 31,258 | — | plan? |
| Jan 2, 2015 FForm 4 → | Jan 8, 5:20 pm EST | Timothy J CreechSee Remarks | 3,248 | $114.94 | $373,325 | 30,537 | — | plan? late |
| Jan 2, 2015 FForm 4 → | Jan 8, 5:08 pm EST | William P ForbesEVP Research&Devel & CDO | 10,997 | $114.94 | $1,263,995 | 114,594 | — | plan? late |
| Jan 2, 2015 FForm 4 → | Jan 8, 5:01 pm EST | Rick D ScruggsExecutive Vice President | 8,408 | $114.94 | $966,416 | 78,962 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2015 DForm 4 → | Apr 3, 11:45 am EDT | Alonzo Thomas DActing President and CEO, Director | 15,000 | — | — | 0 | — | |
| Apr 1, 2015 DForm 4 → | Apr 3, 11:40 am EDT | William P KeaneDirector | 15,000 | — | — | 0 | — |